SRTD Biotech GmbH is a Munich-based biotechnology company focused on the development of selectively expressed RNAs (seRNAs) and fusogenic lipid nanoparticles (LNPs) for organ-specific targeting in advanced therapeutics.
CRS offers R&D-grade pDNA, RNA and LNP production, construct design, lipid screening and analytical services for preclinical studies, with seamless scale-up to GMP clinical supply.
